[Thread]. 1. What will influence the severity of a 4th #COVID19 wave?
New variants.
We don't know if there will be a new variant, but we do know that each previous SA wave was driven by a different variant:
Wave 1: Original form of SARS-CoV-2
Wave 2: Beta
Wave 3: Delta
2. What can we not for certain say about a 4th #COVID wave?
* We cannot predict if + when a new variant will emerge + what it will look like
* SA's modellers = decided to use a variant that can escape immunity (make jabs work less well) 4 their modelling 2 look @ a 4th wave
3. What else can influence what a 4th #COVID19 wave looks like?
Vaccination coverage.
Where are we at?
* About 16 million adults, or 40% of adults, have received at least one dose of vaccine
* 34% of adults = fully vaccinated
.
4. Where is SA at with #COVID19 infections? 1. 60-70% of SAs have likely had #COVID (this is what modellers estimate using different data sources) 2. This estimated infection rate is much higher than in the Northern Hemisphere
5. Modellers made the following assumptions for their estimations: 1. 70% of adults (and 75% of 60+) would have received one jab by the end of March 2. Vaccines = not 100% effective 3. Vaccine effectiveness @ #COVID infection wanes after 6 mnths, but no waning 4 hospitalisation
6. Modellers considered 4 scenarios: 1. Changes in behaviour in terms of mask wearing, social distancing, etc. (Think: Dec holidays; people = tired of measures) 2. A variant that reduces vaccine effectiveness by 25% emerges
They looked @ different combinations of these things.
7. Scenario 1 a and b:
a. If people slow down with mask wearing, etc in Nov (no new variant):
- Peaks of hospital admission = smaller than in previous waves
b. If they slow down in Jan (no new variant):
- Hospitalisations = later, but in nrs = about the same as in "a"
8. If we vaccinate a higher % of people of 60+ than in younger groups, there will be far fewer hospital admissions (60+ = most likely to fall seriously ill).
9. Scenario 2: People return to the way they behaved before #COVID19 (no masks, etc) despite increased infections (unlikely scenario) amidst a new variant that can escape immunity emerging.
- Admissions = higher than in scenario 1, but lower than in Wave 2 and 3, except for EC
10. Scenario 3: A new variant emerges that makes jabs 25% less effective, but people don't slow down with protective measures at all (unlikely scenario)
- Slow increase in admissions, but with higher peaks than in scenario 1
11. Scenario 4 (most realistic): New variant, people slow down with protective measures 1. Admission peaks lower than in Wave 2 + 3 (NC/FS = hard to model) 2. That doesn't mean hospitals won't run out of capacity as most of their resources = no longer allocated to just #Covid19
12. If we have a high (75%) vaccination rate among 60+ then hospital admissions for Wave 4's scenario 4 (new variant, slow down in protective measures) will be reduced significantly.
13. How many admissions did we have in previous waves?
Wave 1: 103,400
Wave 2: 149,300
Wave 3: 177,500
How many admissions will we have with scenario 4 for Wave 4?
About half of those in Wave 2 and 3
14. What will #COVID19 infections look like? In all scenarios they're still high, but the difference is that hospital admissions = lower because vaccines protect you against falling seriously ill with #COVID.
15: The crux?
Modelling predicts, with all 4 scenarios, that Wave 4 will generally have fewer people falling seriously ill with #COVID19 (so fewer hospital admissions) because of vaccination. So still many infections, but fewer hospital admissions and deaths.
🧵1. BREAKING: The peer-reviewed results of the study of a 6-monthly jab, #lenacapavir, in which not a single of the 2134 women between 16-25 years who received the jab contracted #HIV, were released at #Aids2024.
2. Women often find it hard to adhere to daily #oralPrEP. In the Purpose 1 trial, 91.5% of women returned on time for their next #lenacapavir jab at 26 weeks and 92.8% at week 52.
3. Only 4 women out of 2134 (0.2%) who received #lenacapavir dropped out of the trial because of injection-site reactions.
[Thread] 12 things to know about the the proportion of pregnant women infected with #HIV from SA’s latest antenatal HIV survey. The survey is conducted by the @nicd_sa.
(Analysis of our 95-95-95 goals in my next thread later in Jan).
1/12
2. What is the antenatal #HIV survey?
1. It measures the % of HIV+ pregnant women between the ages of 15 + 49. 2. Only women using state pregnancy clinics take part. 3. The survey has been conducted each year between 1990-2015, then in 2017, 2019 +2022.
3. How many pregnant women between 15-49’s blood was tested for #HIV? 37 828 out of 40 542 collected samples.
- 37 7171 = Black African women
- 37 541 didn’t live with the dad of their child
- 35,635 of dads were 5 years+ older than moms (this makes them more likely to get HIV)
JUST IN [Thread]:
1.@healthza's Lesley Broomberg:
An extra #COVID19 booster jab for people of 18+ in SA will become available towards the end of JANUARY
- People of 50+ qualify for a 5th dose
- People of 18+ qualify for a 4th dose
2. Lesley Broomberg: Can you mix and match with additional boosters? Yes. You can choose whether you want a #JnJ or #Pfizer booster.
3. Lesley Broomberg:
Will teens of 12-17 qualify for boosters? Not at this stage. Why not? The #VMAC = not recommended booster doses for 12-17, based on an understanding that the protection provided by 2 #Pfizer doses = adequate, as 12-17 = @ low risk of severe #COVID19 illness
[Thread] #JoePhaahla:
- Genomic surveillance Network reported the detection of the new subvariant XBB.1.5 in SA of a sample of a patient tested on 22 Dec
- Details of the patient = not known, it was a random sample taken for testing
- XBB.1.5 = also common in US
2. XBB.1.5 = common in US
#JoePhaahla:
- 97%+ of #COVID19 cases worldwide = still #Omicron
- XBB.1.5 cases = no major change in hospitalisations or deaths
- Immunity of SAs (vax and natural immunity) = still strong, so that is why we haven't seen much change in terms of hospital admissions/deaths
Which APIs will Aspen use?
India's Serum Institute's
2. Why is it NB that an African company makes these jabs?
#Africa imports almost all its jabs. #COVID19 showed us this results in Africa being last in line to get vaccines during pandemics. The grant to Aspen is 1 of the 1st steps to change that.
3. What's the goal?
By 2040, the African Union wants #Africa to make 60% of the jabs the continent uses.
Why?
So that Africa is better equipped 2 respond 2 outbreaks (by developing the ability to make jabs + have technology in place to also make new jabs during pandemics).
🧵1. BREAKING: @SAHPRA1 has confirmed the registration of the #HIV prevention jab, #CABLA in South Africa. On Thursday, #ViiVHealthcare issued their statement.
2. Who can use the jab? @SAHPRA1 didn't specify restrictions for use in their statement, only that it is "a highly effective option for people at substantial risk of #HIV infection."
3. How does the jab work? It uses an #ARV called cabotegravir that prevents #HIV from replicating and entering someone’s cells. It’s taken every two months. Read my latest story for more. bit.ly/3ER7ejq